NCT06050798View on ClinicalTrials.gov

Hematological Disorder in Patients With Angiodysplasia

Not yet recruitingOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

September 1, 2026

Study Completion Date

October 1, 2026

Conditions
AngiodysplasiaHematological Disease
Interventions
DIAGNOSTIC_TEST

Von willebrand antigen

Von willebrand antigen change and hematological disorder in patients with angiodysplasia

All Listed Sponsors
lead

Assiut University

OTHER

NCT06050798 - Hematological Disorder in Patients With Angiodysplasia | Biotech Hunter | Biotech Hunter